7 more fatalities take coronavirus toll to 56; infections climb to 8,611
Seven people died in Israel as a result of the coronavirus Monday, the Health Ministry and hospitals said, raising the death toll to 56.Government to announce nationwide lockdown until Friday
The Shaare Zedek Medical Center in Jerusalem said a man aged 77 and a woman aged 91 had died at the hospital. Both had multiple underlying health conditions.
And Tel Aviv’s Ichilov Hospital announced the deaths of a 72-year-old man and an 87-year-old woman, who were also said to suffer from preexisting health complications.
A 90-year-old woman with preexisting conditions died in a Jaffa facility for coronavirus patients. She was moved there from Beersheba’s Mishan assisted living facility, and was the seventh person from the nursing home to die of the virus.
On Monday morning, the Yitzhak Shamir Medical Center in Be’er Yaakov near Tel Aviv announced there had been three fatalities at the hospital in the past 24 hours.
The number of confirmed coronavirus cases rose to 8,611 on Monday morning, up only 181 from the evening tally a day earlier, continuing a slowdown that has largely been attributed to ongoing social distancing.
There are 141 patients in serious condition, including 107 on ventilators, and a further 191 in moderate condition. The ministry said 585 patients had recovered from the virus.
Prime Minister Benjamin Netanyahu is expected to announce tough new restrictions on public movement on Monday evening, preventing all travel between cities from Tuesday afternoon until Friday morning.Italian officials okay experimental Israeli drug for use on COVID-19 patients
The restrictions, set to be approved by ministers overnight, will also limit movement within towns and cities - only permitting access to shops in the immediate vicinity of residents' homes - amid fears that the Passover holiday could lead to an aggravation of the coronavirus outbreak.
Increased lockdown measures come at the expense of pinpoint containment measures which discussed overnight Sunday, targeting several cities with particularly high rates of infection.
The decision comes against the backdrop of a rising death toll, which climbed to 56 on Monday. Confirmed cases of the virus increased to 8,611, including 141 patients in severe condition.
A total of 107 patients currently require a ventilator - an increase of less than 1% during the past 24 hours. Some 585 people have recovered from the illness to date.
Haredi towns and cities continue to represent the hotspot of the coronavirus outbreak in Israel, with the highest number of confirmed cases per 100,000 people located in Efrat (656.1), Kiryat Yearim (634.4), Bnei Brak (622.5) and Kfar Habad (585.6).
As of Monday morning, the two cities with the greatest number of confirmed cases were Jerusalem (1,316 cases) and Bnei Brak (1,222). Tel Aviv-Jaffa was home to the third most cases, with a far more modest 370 incidences of the disease.
Health Minister Ya’acov Litzman reacted angrily after municipal workers from Ramat Gan put up fences overnight between the city and neighboring Bnei Brak, restricting pedestrian movement between the cities. The Interior Ministry subsequently ordered Ramat Gan Mayor Carmel Shama-Hacohen to remove the barriers on Monday morning.
"The residents of Bnei Brak, together with all cities and other areas with large concentrations of haredi residents, should not be subject to discrimination," said Litzman, who tested positive for coronavirus last week. "I urge the mayor of Ramat Gan to avoid provocative steps causing friction between the populations."
Tel Aviv and North Carolina-based RedHill BioPharma announces that Italian officials have approved use of one of its experimental treatments for COVID-19 patients under a compassionate use program.
The chemical compound, opaganib, is still in testing stages as a drug for relieving lung inflammations, such as pneumonia, and doctors hope it could help COVID-19 patients with other underlying conditions.
“The approved opaganib expanded access program allows physicians in the three major hospitals in Italy to treat patients at high risk of developing pneumonia and those with pneumonia, including acute respiratory distress syndrome, secondary to SARS-CoV-2 infection,” says Dr. Mark L. Levitt, medical director at RedHill.
The Italian National Institute for Infectious Diseases and Central Italian Ethics Committee okay the treatment for use on 160 patients in three major hospitals.